Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01326494

Enrollment

Registered

2011-03-31

Start date

2011-04-30

Completion date

2021-05-31

Last updated

2021-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Upper Respiratory Tract Infection

Keywords

Upper Respiratory Tract Infection, Asthma, URTI induced exacerbation of Asthma

Brief summary

The purpose of this study is to investigate the benefits of giving filled prescription of a medication to be used upon early onset of symptoms of URTI induced asthma. The hope is to reduce the need to present to Health Care centres for treatment.

Detailed description

In Canada, asthma affects more the 12% of children. Exacerbation are a common feature of asthma. In children, upper respiratory tract infection (URTI's) are responsible for over 80% of asthma exacerbation. Experts in asthma care acknowledge this critical problem and have developed guidelines to reduce asthma exacerbation. The criteria for participation in this study to have 2 or more presentations to a Health Service centre in the past 12 months for URTI induced asthma. These patients will be followed and interviewed monthly over a 12 month period to investigate whether the use of Oral cortico-steroids upon early onset of URTI induced asthma prevents the need for presentation to hospital

Interventions

DRUGArm 1 Oral Cortico Steroids

Prednisolone: 1 mg / kg per day course of dose for 5 days up to child's weight of 20 kgs. Dexamethasone: 0.3mg/kg per dose for 3 days (minimum weight 20 kgs )

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

12 Months to 18 Years

Healthy volunteers

Inclusion criteria

* 2 or more presentations to Emergency department in a 12 month period

Exclusion criteria

* less then 2 presentations to Emergency department in a 12 month period

Design outcomes

Primary

Measure	Time frame	Description
Reduction of representation to Health Services for Exacerbation of URTI induced asthma	One year	To review the effect of medication given at early onset of symptoms have on reducing the presentation to Health Services and Emergency Departments.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026